MEDICAL PROPERTIES TRUST INC - COMMON STOCK (MPW)

Historical Holders from Q1 2014 to Q3 2025

Symbol: MPW on NYSE
Type / Class: Equity / COMMON STOCK
Shares outstanding: 599,075,356
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 334,944,896
Holdings value: $1,699,262,626
% of all portfolios: 0.002%
Number of holders: 451
Number of buys: 204
Number of sells: -242
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of MEDICAL PROPERTIES TRUST INC - COMMON STOCK (MPW)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	11.76%	-8.1%	$304,770,246	-$26,881,138	70,712,354	-8.1%	The Vanguard Group	30 Jun 2025
BlackRock, Inc.	11.5%	-12.3%	$349,940,110	-$48,769,836	69,021,718	-12.2%	BlackRock, Inc.	30 Sep 2025
Yet Daniel	8.69%	0%	$286,467,289		52,179,834	0%	Yet Daniel	31 Dec 2024
He Zhengxu	7.1%		$233,191,335		42,475,653		He Zhengxu	31 Dec 2024
STATE STREET CORP	4.5%		$136,679,042		26,958,391		STATE STREET CORPORATION	30 Sep 2025

Institutional Holders of MEDICAL PROPERTIES TRUST INC - COMMON STOCK (MPW)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	334,944,896	$1,699,262,626	-$55,364,549	$179,018,592	$61,968,618	$5.07	451
2025 Q2	346,359,737	$1,495,488,279	-$28,736,925	$241,260,110	$46,878,175	$4.31	470
2025 Q1	352,209,087	$2,125,578,499	-$58,753,857	$333,161,448	$87,275,039	$6.03	461
2024 Q4	364,140,280	$1,440,661,110	-$84,401,941	$179,311,515	$78,911,932	$3.95	459
2024 Q3	380,711,874	$2,228,735,146	-$4,753,777	$279,669,860	$176,676,165	$5.85	497
2024 Q2	384,396,833	$1,662,240,655	-$188,245,405	$125,298,700	$99,602,807	$4.31	496
2024 Q1	424,664,838	$1,995,027,375	-$18,980,315	$156,770,111	$120,884,469	$4.7	503
2023 Q4	428,890,626	$2,111,810,406	-$136,873,564	$113,218,375	$62,685,616	$4.91	531
2023 Q3	454,281,821	$2,480,525,003	-$78,898,529	$218,766,225	$90,087,410	$5.45	531
2023 Q2	463,878,507	$4,297,994,880	+$141,747,897	$291,838,490	$157,765,803	$9.26	590
2023 Q1	451,183,782	$3,719,642,326	-$262,144,273	$270,966,752	$104,779,762	$8.22	616
2022 Q4	488,252,588	$5,452,061,663	+$37,798,258	$337,981,438	$78,151,915	$11.14	631
2022 Q3	484,428,151	$5,756,300,968	-$21,450,008	$262,941,636	$53,327,000	$11.86	587
2022 Q2	481,852,640	$7,371,230,100	+$22,678,633	$122,473,664	$50,989,342	$15.27	587
2022 Q1	482,269,853	$10,203,330,374	-$158,725,843	$44,049,856	$47,010,000	$21.14	596
2021 Q4	487,220,555	$11,515,147,708	+$64,605,116	$51,577,000	$44,716,000	$23.63	623
2021 Q3	485,197,693	$9,746,978,248	+$189,249,087	$41,298,000	$44,504,000	$20.07	554
2021 Q2	475,903,550	$9,573,743,533	-$38,575,586	$34,580,000	$23,443,000	$20.1	552
2021 Q1	477,569,346	$10,170,774,354	+$767,988,615	$21,553,000	$21,892,000	$21.28	542
2020 Q4	440,535,424	$9,601,798,805	+$145,687,601	$16,209,000	$21,151,000	$21.79	529
2020 Q3	434,850,813	$7,672,111,150	-$89,246,721	$33,390,000	$23,945,000	$17.63	508
2020 Q2	438,302,721	$8,247,356,867	+$163,579,611	$21,405,000	$21,603,920	$18.8	487
2020 Q1	438,107,480	$7,579,206,993	+$44,159,294	$13,714,000	$21,988,000	$17.29	487
2019 Q4	434,921,648	$9,188,540,428	+$1,329,258,104	$10,712,000	$17,374,000	$21.11	503
2019 Q3	372,931,323	$7,298,105,216	+$1,042,421,504	$11,619,000	$34,340,000	$19.56	447
2019 Q2	319,641,690	$5,579,025,818	+$24,125,844	$8,708,000	$21,870,000	$17.44	430
2019 Q1	319,625,455	$5,919,376,940	+$528,959,878	$4,859,000	$15,611,000	$18.51	461
2018 Q4	291,672,632	$4,693,270,165	+$143,052,970	$3,503,000	$4,917,000	$16.08	417
2018 Q3	282,478,745	$4,212,156,998	-$16,013,010	$4,034,000	$6,300,000	$14.91	369
2018 Q2	285,150,394	$4,004,241,560	-$64,575,998	$3,241,000	$4,318,000	$14.04	365
2018 Q1	289,910,547	$3,769,829,055	-$75,409,094	$3,732,000	$1,998,000	$13	368
2017 Q4	295,407,955	$4,071,496,355	-$62,481,167	$3,256,000	$780,000	$13.78	362
2017 Q3	299,432,637	$3,932,543,121	-$108,080,406	$8,106,000	$2,277,000	$13.13	331
2017 Q2	308,216,464	$3,965,816,268	+$338,966,743	$6,216,000	$2,815,000	$12.87	344
2017 Q1	288,626,016	$3,721,308,399	+$429,384,705	$4,339,000	$5,884,000	$12.89	320
2016 Q4	292,687,166	$3,601,977,896	+$332,032,049	$2,189,000	$4,266,000	$12.3	331
2016 Q3	263,942,764	$3,896,382,252	+$943,656,473	$2,941,000	$5,631,000	$14.77	338
2016 Q2	200,238,984	$3,046,190,701	+$79,814,131	$2,558,000	$1,761,000	$15.21	308
2016 Q1	195,221,274	$2,533,580,507	+$78,948,528	$2,666,000	$2,776,000	$12.98	283
2015 Q4	188,963,879	$2,176,280,685	-$61,610,034	$1,869,000	$1,583,000	$11.51	292
2015 Q3	194,679,243	$2,154,318,392	+$276,238,771	$3,334,000	$1,583,000	$11.06	280
2015 Q2	169,820,078	$2,226,416,030	+$15,809,176	$4,299,000	$1,188,000	$13.11	277
2015 Q1	168,382,635	$2,483,475,059	+$438,467,561	$2,013,000	$2,459,000	$14.74	268
2014 Q4	137,634,064	$1,897,893,409	+$87,768,285	$832,000	$26,000	$13.78	251
2014 Q3	132,465,807	$1,624,094,725	+$24,706,086	$1,094,000	$431,000	$12.26	245
2014 Q2	129,983,567	$1,721,143,200	-$62,933,068	$1,364,000	$572,000	$13.24	233
2014 Q1	132,519,595	$1,695,321,266	+$114,316,797	$1,439,000	$1,038,000	$12.79	243